BridgeBio Pharma (BBIO) Cost of Revenue (2021 - 2026)
BridgeBio Pharma's Cost of Revenue was $15.05 million in Q2 2026, up 311.9% from $3.65 million a year earlier and up 51.4% from the prior quarter.
BridgeBio Pharma (BBIO) Cost of Revenue (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, BridgeBio Pharma's Cost of Revenue was $39.66 million through Jun 30, 2026, up 341.9% year-over-year; for FY2025, it was $20.96 million, up 440.5% from FY2024.
- Cost of Revenue shows a four-year compound annual growth rate of 61.1% (FY2021 to FY2025).
- In earlier years, Cost of Revenue was $3.88 million in FY2024 (+58.5%), $2.45 million in FY2023 (-28.8%), $3.43 million in FY2022 (+10.3%) and $3.11 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Cost of Revenue in data going back to Q2 2021.
- Compared with a year earlier, Cost of Revenue has increased for seven straight quarters, with growth averaging 372.0% over the last eight quarters.
- The best year-over-year quarter for Cost of Revenue over five years was Q3 2025 (growth of 997.5%); the worst was Q4 2022 (a decline of 58.3%).
- Per Business Quant data, BBIO's Cost of Revenue in the three quarters before Q2 2026 was $9.94 million (Q1 2026), $8.11 million (Q4 2025) and $6.56 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | BridgeBio Pharma | 13.13 Bn | 10.25 Bn | 228.63 Mn | 15.05 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.05 Mn |
| Mar 31, 2026 | 9.94 Mn |
| Dec 31, 2025 | 8.11 Mn |
| Sep 30, 2025 | 6.56 Mn |
| Jun 30, 2025 | 3.65 Mn |
| Mar 31, 2025 | 2.64 Mn |
| Dec 31, 2024 | 2.08 Mn |
| Sep 30, 2024 | 598,000.00 |
| Jun 30, 2024 | 598,000.00 |
| Mar 31, 2024 | 598,000.00 |
| Dec 31, 2023 | 598,000.00 |
| Sep 30, 2023 | 598,000.00 |
| Jun 30, 2023 | 599,000.00 |
| Mar 31, 2023 | 651,000.00 |
| Dec 31, 2022 | 647,000.00 |
| Sep 30, 2022 | 739,000.00 |
| Jun 30, 2022 | 700,000.00 |
| Mar 31, 2022 | 1.35 Mn |
| Dec 31, 2021 | 1.55 Mn |
| Sep 30, 2021 | 1.45 Mn |
BridgeBio Pharma Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=BBIO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();